TNF Pharmaceuticals, Inc. ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, announced that data ...

Although the validity of TBI diagnoses has been shown to be excellent, we were unable to exclude patients with non-operated chronic subdural haematomas due to limitations in the ICD-10 coding.

Isomyosamine (ICD-10-CM code M62.84) is a novel plant alkaloid small molecule ... The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy.

People with temporal lobe epilepsy (TLE) have frequently been described as having ... emphasizing the potential for harmonization between frameworks such as the ICD-11 and DSM-5. Furthermore, ...

When you replace an older cell phone or TV with a new high-resolution device, the visuals can be strikingly different—all of ...

The SynGAP Research Fund (SRF) dba Cure SYNGAP1, a 501(c)(3) nonprofit organization, has awarded a $65,000 grant to Dr. Julia ...

Investigators in the laboratory of Gemma Carvill, Ph.D., assistant professor in the Ken and Ruth Davee Department of Neurology Division of Epilepsy/Clinical Neurophysiology, have discovered novel ...

Epilepsy is one of the most common serious brain conditions: nearly 52 million people were living with epilepsy in 2021, ...

Seizures and dreams are linked among patients with epilepsy, as DRF was associated with seizure frequency and localization.

More than 50 million people worldwide live with epilepsy, with approximately half of them being children. For about one-third ...